Robert L. Nussbaum, Chief Medical Officer at Invitae Corp (NVTA), sold 7,048 shares at $4.55 ($32K) on 2022-08-16, disclosed to the SEC on 2022-08-18.
Seasonal sale ($32k) by Chief Medical Officer — this insider has traded NVTA in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| NVTA | SELL | 2023-03-15 | $4K | — | Filing → |
| NVTA | SELL | 2022-05-19 | $23K | — | Filing → |
| NVTA | SELL | 2022-03-16 | $262K | — | Filing → |